Clinical Trial Update: A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating XSTEM-VLU for difficult-to-heal venous leg ulcers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• XSTEM-VLU

Snippet

Sponsor: Xintela AB | Conditions: Venous Leg Ulcer | Phase 1, Phase 2 | Status: RECRUITING